Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Context Therapeutics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −3 vs. Q1 2025
- Shares held
- 68.6M
- −2.79M (−3.9%) vs. Q1 2025
- Total value
- $45.0M
- +$1.25M (+2.9%) vs. Q1 2025
- New holders
- 4
- 9 more added
- Sold out
- 7
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 113 | $74 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 370 | $242 | 0.00% | −62−14.4% | Reduced |
| Bank of America Corp | 543 | $356 | 0.00% | +99+22.3% | Added |
| Newbridge Financial Services Group, Inc. | 2,000 | $1.31K | 0.00% | +2,000 | New |
| Morgan Stanley | 3,500 | $2.29K | 0.00% | +3,400+3,400.0% | Added |
| Tower Research Capital LLC (TRC) | 7,414 | $4.86K | 0.00% | −5,890−44.3% | Reduced |
| Advisor Group Holdings, Inc. | 10,500 | $6.83K | 0.00% | +500+5.0% | Added |
| Congress Wealth Management LLC | 15,000 | $9.83K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,067 | $11.2K | 0.00% | −31,604−64.9% | Reduced |
| Caxton Corp | 18,403 | $12.1K | 0.12% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $13.1K | 0.00% | +10,000+100.0% | Added |
| GTS Securities LLC | 44,176 | $28.9K | 0.00% | +44,176 | New |
| Clear Harbor Asset Management, LLC | 57,804 | $37.9K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 100,000 | $65.5K | 0.07% | +10,000+11.1% | Added |
| Mill Creek Capital Advisors, LLC | 104,631 | $68.6K | 0.00% | +104,631 | New |
| Qube Research & Technologies Ltd | 106,779 | $70.0K | 0.00% | −67,530−38.7% | Reduced |
| Northern Trust Corp | 113,565 | $74.4K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 125,852 | $82.5K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 132,786 | $87.0K | 0.00% | −36,174−21.4% | Reduced |
| State Street Corp | 152,607 | $100.0K | 0.00% | 00.0% | Unchanged |
| Luminus Management LLC | 328,222 | $215.1K | 0.06% | +328,222 | New |
| ADAR1 Capital Management, LLC | 351,094 | $230.0K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 363,930 | $238.4K | 0.00% | −61,570−14.5% | Reduced |
| Affinity Asset Advisors, LLC | 518,025 | $339.4K | 0.05% | −142,564−21.6% | Reduced |
| Geode Capital Management, LLC | 637,810 | $418.1K | 0.00% | −1,409−0.2% | Reduced |
| Woodline Partners LP | 680,188 | $445.7K | 0.00% | −681,000−50.0% | Reduced |
| BlackRock, Inc. | 848,970 | $556.2K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 1,341,636 | $879.0K | 0.35% | +13,284+1.0% | Added |
| Alyeska Investment Group, L.P. | 1,663,355 | $1.09M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,935,484 | $1.27M | 0.09% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,440,330 | $1.60M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,360,582 | $2.20M | 0.00% | +107,115+3.3% | Added |
| Franklin Resources Inc | 4,003,380 | $2.62M | 0.00% | 00.0% | Unchanged |
| Great Point Partners LLC | 4,683,711 | $3.07M | 2.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 7,407,906 | $4.85M | 1.57% | +40,000+0.5% | Added |
| Nextech Invest, Ltd. | 7,419,355 | $4.86M | 0.92% | 00.0% | Unchanged |
| Deep Track Capital, LP | 7,419,355 | $4.86M | 0.16% | 00.0% | Unchanged |
| Avidity Partners Management LP | 7,477,255 | $4.90M | 0.98% | +550.0% | Added |
| MPM Oncology Impact Management LP | 14,705,882 | $9.64M | 1.67% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −1,157,448−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −950,166−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −189,853−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −67,631−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −41,216−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,673−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −80−100.0% | Sold out |